[Seite 25↓]

Eigene Publikationen:

Chen Y, Knösel T, Kristiansen G , Pietas A, Garber ME, Matsuhashi S, Ozaki I, Petersen I. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol. 2003; 200: 640-646.

Denkert C, Winzer KJ, Muller BM, Weichert W, Pest S, Kobel M, Kristiansen G , Reles A, Siegert A, Guski H, Hauptmann S. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer. 2003; 97: 2978-87.

Grützmann R, Foerder M, Alldinger I, Staub E, Brümmendorf T, Röpcke S, Li X, Kristiansen G , Jesnowski R, Sipos B, Löhr M, Lüttges J, Ockert D, Klöppel G, Saeger HD, Pilarsky C. Gene expression profiles of microdissected pancreatic ductal adenocarcinomas. Virchows Archiv 2003, im Druck.

J Elgeti U, Jung K, Lein M, Brux B, Sinha P, Rudolph B, Kristiansen G , Hauptmann S, Schnorr D, Loening SA. Komplex-gebundenes oder freies prostata-spezifisches Antigen: welche Komponente sollte zur Differenzierung zwischen benigner Prostatahyperplasie und Prostatakarzinom bestimmt werden? J Lab Med 1999; 23: 645-53.

Jung K, Brux B, Lein M, Rudolph B, Kristiansen G , Hauptmann S, Schnorr D, Loening SA, Sinha P. Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implications. Clin Chem. 2000; 46: 47-54.

Jung K, Stephan C, Elgeti U, Lein M, Brux B, Kristiansen G , Rudolph B, Hauptmann S, Schnorr D, Loening SA, Sinha P. Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer? Int J Cancer. 2001; 93: 759-65.

Jung M, Romer A, Keyszer G, Lein M, Kristiansen G , Schnorr D, Loening SA, Jung K. mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissue. Prostate. 2003; 55: 89-98.

Kristiansen G *, Denkert C*, Schluns K, Dahl E, Pilarsky C, Hauptmann S. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol. 2002; 161: 1215-21.

Kristiansen G , Pilarsky C, Pervan J, Stürzebecher B, Stephan C, Jung K, Loening S, Rosenthal A, Dietel M. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 2003, im Druck.

Kristiansen G *, Pilarsky C*, Wissmann C, Stephan C, Weissbach L, Loy V, Loening S, Dietel M, Rosenthal A. ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate. 2003; 54: 34-43.

Kristiansen G , M. Sammar M, Altevogt P. Tumour biology aspects of CD24, a mucin-like adhesion molecule. Histochemical Journal 2003, im Druck.

Kristiansen G , Schluns K, Yongwei Y, Denkert C, Dietel M, Petersen I. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Br J Cancer. 2003; 88: 231-6.

Kristiansen G , Schluns K, Yongwei Y, Dietel M, Petersen I. CD10 expression in non-small cell lung cancer. Anal Cell Pathol. 2002; 24: 41-6.

Kristiansen G , Winzer, KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M. CD24 Expression is a New Prognostic Marker in Breast Cancer. Clin Cancer Res 2003, im Druck.

Kristiansen G , Wunderlich W, Fischer F, Roehrig B, Arntz HR, Horstkotte D, Schultheiss HP: Accuracy and precision of the analytic calibration method in quantitative coronary angiography. Comp Cardiol 1996; 23: 553-556.

Kristiansen G , Yu Y, Petersen S, Kaufmann O, Schluns K, Dietel M, Petersen I. Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer. Eur J Cancer. 2001 ; 37: 1089-95.

Kristiansen G , Yu Y, Schluns K, Sers C, Dietel M, Petersen I. Expression of the cell adhesion molecule CD146/MCAM in non-small cell lung cancer. Anal Cell Pathol. 2003; 25: 77-81.

Lichtinghagen R, Musholt PB, Lein M, Romer A, Rudolph B, Kristiansen G , Hauptmann S, Schnorr D, Loening SA, Jung K. Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. Eur Urol. 2002; 42: 398-406.

Lichtinghagen R, Musholt PB, Stephan C, Lein M, Kristiansen G , Hauptmann S, Rudolph B, Schnorr D, Loening SA, Jung K. mRNA expression profile of matrix metalloproteinases 1, 2, 7, 9, 11, 14 and the tissue inhibitors 1, 2, 3 in malignant and nonmalignant prostatic tissue. Anticancer Res 2003; 23: 2617-24.

Magklara A, Scorilas A, Stephan C, Kristiansen GO , Hauptmann S, Jung K, Diamandis EP. Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue. Urology. 2000; 56: 527-32.

Nakamura T, Scorilas A, Stephan C, Yousef GM, Kristiansen G , Jung K, Diamandis EP. Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues. Br J Cancer. 2003; 88: 1101-4.

Stephan C, Jung K, Cammann H, Vogel B, Brux B, Kristiansen G , Rudolph B, Hauptmann S, Lein M, Schnorr D, Sinha P, Loening SA. An artificial neural network considerably improves the diagnostic power of percent free prostate-specific antigen in prostate cancer diagnosis: results of a 5-year investigation. Int J Cancer. 2002; 99: 466-73.

Stephan C, Vogel B, Cammann H, Lein M, Sinha P, Kristiansen G , Schnorr D, Jung K, Loening SA. Die Nutzung von artifiziellen neuronalen Netzwerken zur Risikoabschätzung eines Prostatakarzinoms: Biopsieindikationen im PSA-Bereich 2-20 µg/l. Urologe A 2003; im Druck.

Stephan C, Yousef GM, Scorilas A, Jung K, Jung M, Kristiansen G , Hauptmann S, Bharaj BS, Nakamura T, Loening SA, Diamandis EP. Quantitative analysis of kallikrein 15 gene expression in prostate tissue. J Urol. 2003; 169: 361-4.

Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M, Kristiansen G , Hsieh JC, Ferdinand Hofstaedter F, Arndt Hartmann A, Ruth Knuchel R, André Rosenthal A, Pilarsky C. WIF1 a component of the Wnt-pathway is down-regulated in prostate, breast, lung and bladder cancer. J Pathol 2003; im Druck.

Yousef GM, Stephan C, Scorilas A, Ellatif MA, Jung K, Kristiansen G , Jung M, Polymeris ME, Diamandis EP. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues. Prostate. 2003; 56: 287-92.

Zhang J, Jung K, Lein M, Kristiansen G , Rudolph B, Hauptmann S, Schnorr D, Loening SA, Lichtinghagen R. Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines. Prostate. 2002; 50: 38-45.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
08.06.2005